Malignant Ovarian Neoplasm — Trials

Malignant Ovarian Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,086 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 684
Recruiting: 385
Ph III recruiting: 46
Growth YoY: +9.8%
Industry share: 37%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.8%
Trials / 1,000 deaths: 53.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (437)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03762733	Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies	enrolling by invitation	—	500	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT07078409	Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology	enrolling by invitation	N/A	240	Abramson Cancer Center at Penn MedicineOTHER	1	Aug 27, 2026	clinicaltrials